Landauer Elects Board Member Michael T. Leatherman as Interim Chief Financial Officer

Landauer, Inc. LDR today announced that its Board of Directors has appointed, Michael T. Leatherman, as the Company's Interim Chief Financial Officer, as well as its acting principal financial officer and principal accounting officer, effective September 9, 2011. Leatherman succeeds Jonathon Singer, who had served as CFO since October 2006 and has left the Company in order to accept the chief financial officer position with Sagent Pharmaceuticals, Inc. "Mike has worked with Landauer since 2003, and he has been a Board member for the last three years. He has deep knowledge and history with the Company, understands our core radiation monitoring business and has been instrumental in shaping our growth strategy initiatives. The Board and I are confident that Mike will provide strong continuity as CFO and Treasurer as we search for a permanent Chief Financial Officer," said Bill Saxelby, President and Chief Executive Officer of Landauer, Inc.